An in-depth look to MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. operating, investing, and financing activities

4016 free cash flow for Q1 24 is 25.15 M SAR. For 2023, 4016 free cash flow was 67.49 M SAR and operating cash flow was 88.33 M SAR.